Feb 22 (Reuters) - CogState Ltd (CGS) :
- REMAINS CONFIDENT COGSTATE IS WELL POSITIONED FOR GROWTH AND WILL RECOMMENCE SHARE BUYBACK
- RESOLVED TO COMMENCE A FURTHER ON-MARKET SHARE BUY-BACK OF UP TO 5 MILLION OF ISSUED ORDINARY SHARES OVER NEXT 12 MONTHS
- EXPECT IMPROVED CLINICAL TRIALS SALES BOOKINGS IN 2H24 COMPARED WITH 1H24
- CUSTOMER ENGAGEMENT ON NEW CLINICAL TRIALS EXPECTED TO REMAIN STRONG IN FY24
- EXPECT IMPROVED CLINICAL TRIALS SALES BOOKINGS IN 2H24 COMPARED WITH 1H24
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.72 |
Change
-0.015(0.87%) |
Mkt cap ! $292.8M | |||
| Open | High | Low | Value | Volume |
| $1.73 | $1.73 | $1.72 | $20.12K | 11.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | $1.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 83 | 1 |
View Market Depth
| Last trade - 11.35am 01/08/2025 (20 minute delay) ? |
| CGS (ASX) Chart |